Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nomogram based on baseline clinicopathological characteristics for predicting bladder cancer-specific survival to neoadjuvant chemotherapy in muscle-invasive bladder cancer.
Font A, Domenech M, Buisan O, Lopez H, González A, Etxaniz O, Matas M, Elias X, Gomez M, Figols M, Horneros J, Pardo JC, Notario L, Ruiz de Porras V, Perez I, Areal J, Esteve A. Font A, et al. Among authors: buisan o. World J Urol. 2022 Nov;40(11):2627-2634. doi: 10.1007/s00345-022-04147-4. Epub 2022 Sep 15. World J Urol. 2022. PMID: 36107212
PSA Kinetics as Prognostic Markers of Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate.
España S, Ochoa de Olza M, Sala N, Piulats JM, Ferrandiz U, Etxaniz O, Heras L, Buisan O, Pardo JC, Suarez JF, Barretina P, Comet J, Garcia Del Muro X, Sumoy L, Font A. España S, et al. Among authors: buisan o. Cancer Manag Res. 2020 Oct 16;12:10251-10260. doi: 10.2147/CMAR.S270392. eCollection 2020. Cancer Manag Res. 2020. PMID: 33116879 Free PMC article.
Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment.
Ruiz de Porras V, Wang XC, Palomero L, Marin-Aguilera M, Solé-Blanch C, Indacochea A, Jimenez N, Bystrup S, Bakht M, Conteduca V, Piulats JM, Buisan O, Suarez JF, Pardo JC, Castro E, Olmos D, Beltran H, Mellado B, Martinez-Balibrea E, Font A, Aytes A. Ruiz de Porras V, et al. Among authors: buisan o. Eur Urol. 2021 Jun;79(6):722-733. doi: 10.1016/j.eururo.2020.10.001. Epub 2020 Nov 3. Eur Urol. 2021. PMID: 33153817 Free PMC article.
Variant histologies in bladder cancer: Does the centre have an impact in detection accuracy?
Cimadamore A, Lonati C, Di Trapani E, De Cobelli O, Rink M, Zamboni S, Simeone C, Soria F, Briganti A, Montorsi F, Afferi L, Mattei A, Carando R, Ornaghi PI, Tafuri A, Antonelli A, Karnes RJ, Colomer A, Sanchez-Salas R, Contieri R, Hurle R, Poyet C, Simone G, D'Andrea D, Shariat SF, Galfano A, Umari P, Francavilla S, Roumiguie M, Terrone C, Hendricksen K, Krajewski W, Buisan O, Laukhtina E, Xylinas E, Alvarez-Maestro M, Rouprêt M, Montironi R, Moschini M; European Association of Urology - Young Academic Urologists (EAU-YAU): Urothelial Carcinoma Working Group. Cimadamore A, et al. Among authors: buisan o. Urol Oncol. 2022 Jun;40(6):273.e11-273.e20. doi: 10.1016/j.urolonc.2022.01.008. Epub 2022 Feb 23. Urol Oncol. 2022. PMID: 35216892
[Incomplete urethral duplication].
Rodríguez Tolrá J, Cuadrado Campaña JM, Buisan O, Francés I Comalat A, Franco Miranda E, Serrallach Milá N. Rodríguez Tolrá J, et al. Among authors: buisan o. Actas Urol Esp. 2005 Jul-Aug;29(7):697-9. doi: 10.1016/s0210-4806(05)73321-0. Actas Urol Esp. 2005. PMID: 16180321 Spanish.
13 results